{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:37:48Z","timestamp":1794562668500,"version":"4.9.1"},"reference-count":84,"publisher":"Informa UK Limited","issue":"3-4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pharmacogenomics"],"published-print":{"date-parts":[[2026,4,3]]},"DOI":"10.1080\/14622416.2026.2658438","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T02:13:37Z","timestamp":1776651217000},"page":"111-121","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["The use of cell-free DNA (cfDNA)\/circulating tumor DNA (ctDNA) to guide treatment selection in metastatic breast cancer"],"prefix":"10.1080","volume":"27","author":[{"given":"Oluwaferanmi","family":"Bello","sequence":"first","affiliation":[{"name":"Harvard Medical School","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Rieur","sequence":"additional","affiliation":[{"name":"Harvard Medical School","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelima","family":"Vidula","sequence":"additional","affiliation":[{"name":"Harvard Medical School","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,4,19]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-024-01293-9"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101330"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16020317"},{"issue":"3","key":"e_1_3_4_5_1","first-page":"241","article-title":"Les acides nucl\u00e9iques du plasma sanguin chez l\u2019homme [Nuclear Acids In Human Blood Plasma]","volume":"142","author":"Mandel P","year":"1948","unstructured":"Mandel P, Metais P. Les acides nucl\u00e9iques du plasma sanguin chez l\u2019homme [Nuclear Acids In Human Blood Plasma]. C R Seances Soc Biol Fil. 1948;142(3\u20134):241\u2013243.","journal-title":"C R Seances Soc Biol Fil"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.2011"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02021-w"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-018-0413-5"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104776"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-024-00653-3"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-21-0029"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15010109"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.95320.1"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.3343\/alm.2023.0389"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvaa103"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1385041"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-03508-4"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells14141062"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyaf204"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-024-00642-6"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70943"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25084252"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-006284"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.adk1213"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.102390"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.1838"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3005"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.11.007"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.11.005"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1158\/1557-3265.SABCS24-GS3-01"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.1010"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-024-00708-5"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1213261"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3185-9"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2024.08.011"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.31722"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-024-01823-8"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03215-x"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2025.11.018"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-023-00528-z"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-025-07705-7"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1813904"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2404625"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2501796"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2214131"},{"key":"e_1_3_4_46_1","volume-title":"Presented at: San Antonio Breast Cancer Symposium (SABCS)","author":"Turner NC","year":"2025","unstructured":"Turner NC, Oliveira M, Howell SJ, et al. Capivasertib plus fulvestrant in hormone receptor\u2013positive (hr+) advanced breast cancer (ABC): exploratory ctDNA analyses from the phase 3 CAPItello-291 trial. Abstract RF7-05. In: Presented at: San Antonio Breast Cancer Symposium (SABCS); 2025 Dec 11; San Antonio, TX."},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.3061"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-021-01462-3"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30444-7"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70322-X"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00613-0"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00338"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-1073"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2410858"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00555-1"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2502929"},{"key":"e_1_3_4_57_1","volume-title":"Proceedings of the San Antonio Breast Cancer Symposium","author":"Bidard F","year":"2025","unstructured":"Bidard F, Mayer EL, Park Y, et al. Updated results and an exploratory analysis of ESR1m circulating tumor DNA (ctDNA) dynamics from SERENA-6, a phase 3 trial of camizestrant (CAMI) plus CDK4\/6 inhibitor (CDK4\/6i) for emergent ESR1 mutations during first-line endocrine-based therapy and ahead of disease progression in patients with HR+\/HER2- advanced breast cancer. In: Proceedings of the San Antonio Breast Cancer Symposium; 2025 Dec; San Antonio, TX. Abstract RF7-03."},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2025.10.006"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-0900"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.08.003"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03462-0"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-2933"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-0638"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1802905"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706450"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-25-02075"},{"key":"#cr-split#-e_1_3_4_67_1.1","unstructured":"Vidula N (PI). Evaluation of talazoparib a PARP inhibitor in patients with somatic BRCA mutant metastatic breast cancer: genotyping-based clinical trial. ClinicalTrials.Gov identifier: nCT03990896. [Updated 2025 August 7"},{"key":"#cr-split#-e_1_3_4_67_1.2","unstructured":"cited 2026 Mar 20]. Available from: https:\/\/clinicaltrials.gov\/show\/NCT03990896"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-0138"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-022-00490-2"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-021-01536-1"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-3444"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy263"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-024-00633-7"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abm8729"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00747-5"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-025-00783-2"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1200\/PO.20.00117"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.35292"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-022-00340-1"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.61899"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.03.022"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-282"},{"key":"e_1_3_4_83_1","volume-title":"Abstract presented at: San Antonio Breast Cancer Symposium","author":"Razavi P","unstructured":"Razavi P. GS3-09: multimodal integration of real-world clinical and genomic data for the prediction of CDK4\/6 inhibitors outcomes in patients with HR+\/HER2\u2212 metastatic breast cancer. In: Abstract presented at: San Antonio Breast Cancer Symposium; 2024 Dec 10\u201313; San Antonio, TX. Abstract SESS-2236. Available from: https:\/\/sabcs.org\/Portals\/0\/Documents\/Embargoed\/GS3-09%20Embargoed.pdf"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02605-z"}],"container-title":["Pharmacogenomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14622416.2026.2658438","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T12:49:27Z","timestamp":1779454167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14622416.2026.2658438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":84,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2026,4,3]]}},"alternative-id":["10.1080\/14622416.2026.2658438"],"URL":"https:\/\/doi.org\/10.1080\/14622416.2026.2658438","relation":{},"ISSN":["1462-2416","1744-8042"],"issn-type":[{"value":"1462-2416","type":"print"},{"value":"1744-8042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-11-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}